Communicable Diseases  >>  ciprofloxacin (Q3939)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ciprofloxacin (Q3939) / Bayer, Novartis
NCT01168895: Study in COPD (Chronic Obstructive Pulmonary Disease) Subjects to Investigate Safety, Tolerability, and Pharmacokinetics of Ciprofloxacin After Single Dose Inhalations of 50 mg and 75 mg Ciprofloxacin Inhalation Powder

Completed
1
12
Europe
Cipro Inhale (Ciprofloxacin, BAYQ3939)
Bayer
Infection, Pulmonary Disease, Chronic Obstructive
09/10
09/10
NCT00910351: Cipro Inhaler for Cystic Fibrosis Children Ages 6-12

Completed
1
19
US
Ciprofloxacin (Cipro, BAYQ3939)
Bayer
Pseudomonas Infection
10/10
10/10

Download Options